NRAS Gene NRAS Selective Sequencing of Exons 2 and 3 Genetic Test sale cost 4400 AED
CHEK2 Gene Li-Fraumeni Syndrome Type 2 Genetic Test sale cost 4400 AED CHEK2 Gene Li-Fraumeni Syndrome Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MAX Gene Pheochromocytoma Type 9 Genetic Test sale cost 4400 AED MAX Gene Pheochromocytoma Type 9 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NRAS Gene NRAS Selective Sequencing of Exons 2 and 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NRAS Gene NRAS Selective Sequencing of Exons 2 and 3 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to scrutinize the NRAS gene, particularly focusing on exons 2 and 3. These specific regions of the gene are critical because mutations in these exons are often implicated in various forms of cancer, including melanoma, colorectal cancer, and certain types of leukemia. By selectively sequencing these exons, healthcare providers can gain valuable insights into the genetic underpinnings of a patient’s condition, facilitating personalized treatment plans that are more effective and targeted.

The test is priced at 4400 AED and is performed in the state-of-the-art facilities of DNA Labs UAE. It involves collecting a DNA sample from the patient, which is then analyzed using advanced sequencing technologies to identify any mutations or abnormalities in the specified exons of the NRAS gene. This information is crucial for predicting disease progression, determining the likelihood of developing certain types of cancer, and selecting the most appropriate therapeutic interventions. Given the precision and specialized nature of this test, it represents a significant tool in the arsenal of modern medicine for managing and treating cancer with a genetic component.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NRAS Gene NRAS selective sequencing of exons 2 and 3 Genetic Test

Test Name: NRAS Gene NRAS selective sequencing of exons 2 and 3 Genetic Test

Components: Price 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for NRAS Gene NRAS, selective sequencing of exons 2 and 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NRAS Gene NRAS, selective sequencing of exons 2 and 3 NGS Genetic DNA Test gene NRAS

Test Details

The NRAS gene is a human gene that encodes a protein called NRAS, which is a member of the RAS family of proteins. The NRAS protein is involved in cell signaling pathways that regulate cell growth and division. Mutations in the NRAS gene can lead to abnormal activation of these pathways, contributing to the development of various types of cancer.

Selective sequencing of exons 2 and 3 of the NRAS gene refers to a specific genetic test that focuses on sequencing only these specific regions of the gene. Exons are regions of DNA that contain the coding sequences for proteins, and exons 2 and 3 of the NRAS gene are particularly important for its function.

Next-generation sequencing (NGS) is a high-throughput sequencing technology that allows for the rapid and efficient sequencing of large amounts of DNA. In the context of the NRAS gene, NGS can be used to identify specific mutations or variations in exons 2 and 3 that may be associated with cancer or other diseases.

The NRAS gene, along with other RAS genes, is commonly sequenced in clinical settings to identify mutations that may guide treatment decisions. For example, certain mutations in NRAS are associated with resistance to specific targeted therapies, such as EGFR inhibitors in the treatment of colorectal cancer.

By selectively sequencing exons 2 and 3 of the NRAS gene using NGS technology, clinicians and researchers can gain valuable insights into the genetic makeup of tumors and potentially tailor treatment options for patients based on their specific NRAS mutation status.

Test Name NRAS Gene NRAS selective sequencing of exons 2 and 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NRAS Gene NRAS, selective sequencing of exons 2 and 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NRAS Gene NRAS, selective sequencing of exons 2 and 3 NGS Genetic DNA Test gene NRAS
Test Details

The NRAS gene is a human gene that encodes a protein called NRAS, which is a member of the RAS family of proteins. The NRAS protein is involved in cell signaling pathways that regulate cell growth and division. Mutations in the NRAS gene can lead to abnormal activation of these pathways, contributing to the development of various types of cancer.

Selective sequencing of exons 2 and 3 of the NRAS gene refers to a specific genetic test that focuses on sequencing only these specific regions of the gene. Exons are regions of DNA that contain the coding sequences for proteins, and exons 2 and 3 of the NRAS gene are particularly important for its function.

Next-generation sequencing (NGS) is a high-throughput sequencing technology that allows for the rapid and efficient sequencing of large amounts of DNA. In the context of the NRAS gene, NGS can be used to identify specific mutations or variations in exons 2 and 3 that may be associated with cancer or other diseases.

The NRAS gene, along with other RAS genes, is commonly sequenced in clinical settings to identify mutations that may guide treatment decisions. For example, certain mutations in NRAS are associated with resistance to specific targeted therapies, such as EGFR inhibitors in the treatment of colorectal cancer.

By selectively sequencing exons 2 and 3 of the NRAS gene using NGS technology, clinicians and researchers can gain valuable insights into the genetic makeup of tumors and potentially tailor treatment options for patients based on their specific NRAS mutation status.

SKU: TEST-4549